The province of Ontario has announced that starting Tuesday, April 20, the AstraZeneca COVID-19 vaccine will be offered to individuals aged 40 and over at pharmacies across the province. Eligible individuals can book an appointment at participating pharmacies by accessing: https://covid-19.ontario.ca/vaccine-locations Based on the review of data from Europe and the United Kingdom, Health Canada...
Tag: Pharmacy
Pharmascience Inc. recalls certain lots of over-the-counter ranitidine
Pharmascience Inc. is recalling 13 additional lots of its store-brand over-the-counter ranitidine products (75 mg strength tablet) after tests found NDMA, a nitrosamine impurity, above accepted levels. HMC
Stockpiling drugs can lead to local shortages: Canadians urged not to buy more medication than usual during the COVID-19 pandemic
Health Canada understands the stress caused by the COVID-19 pandemic and recognizes that Canadians may be concerned about not being able to get medications they rely on for themselves and their loved ones. While the Government of Canada recommends that Canadians refill their prescriptions now so that they do not have to go to a...
Certain Metformin diabetes drugs recalled due to the presence of NDMA
Ranbaxy Pharmaceuticals Canada Inc. is recalling six lots of its prescription RAN-Metformin drug from the Canadian market. Company testing identified two lots (#AJY8006A and #AJY8007A) with levels of NDMA above what is considered acceptable if the drug were to be taken over a lifetime. The company is recalling an additional four lots (#AJY8005A, #AJY8005B, #AJY8008A...
Health Canada updates Canadians on shortage situation involving EpiPen (0.3 mg) auto-injectors
Following Health Canada’s most recent communication regarding a shortage of EpiPen (0.3 mg) and EpiPen Jr (0.15 mg) auto-injectors, Pfizer Canada has advised Health Canada that supply of EpiPen in the 0.3 mg format is expected to be very limited at pharmacies during the month of August. Contact your pharmacies for further updates. HMC